Gene · 1195
Papers1,704
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,704
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Defining the Active Conformation of Typical Protein Kinase Domains from Substrate-Bound PDB Structures Enables Active-State AlphaFold2 Models for All 437 Human Catalytic Protein Kinases. | bioRxiv | 2026 | 41757035 | PubTator, text mining | PubMed |
| From Latent Manifolds to Targeted Molecular Probes: An Interpretable, Kinome-Scale Generative Machine Learning Framework for Family-Based Kinase Ligand Design. | Biomolecules | 2026 | 41750280 | PubTator, text mining | PubMed |
| Advances in the lectin pathway in systemic lupus erythematosus: from clinical correlations and mechanisms to targeted interventions. | Inflamm Res | 2026 | 41741777 | PubTator, text mining | PubMed |
| CLK1 is a potential tumor suppressor for NSCLC by regulating cell proliferation and immune infiltration. | Front Cell Dev Biol | 2026 | 41737282 | PubTator, text mining | PubMed |
| Advances in solid handling for continuous flow synthesis of specialty chemicals and pharmaceuticals. | Commun Chem | 2026 | 41730978 | PubTator, text mining | PubMed |
| Molecular characterization and seasonal expression profiling of circadian clock genes in relation to obligatory diapause in the Sunn Pest, Eurygaster integriceps (Hemiptera: Scutelleridae). | J Insect Physiol | 2026 | 41713555 | PubTator, text mining | PubMed |
| Computational Drug Repurposing for Alzheimer's Disease via Sheaf Theoretic Population-Scale Analysis of snRNA-Seq Data. | J Med Chem | 2026 | 41697185 | PubTator, text mining | PubMed |
| Decoding SR protein regulation: kinases, phosphatases, and therapeutic targeting strategies. | Cell Oncol (Dordr) | 2026 | 41636961 | PubTator, text mining | PubMed |
| Single-cell exon deletion profiling reveals splicing events that shape gene expression and cell state dynamics. | Nat Commun | 2026 | 41633991 | PubTator, text mining | PubMed |
| Thorn specification in citrus plants by an SHI/STY family transcription factor. | Curr Biol | 2026 | 41633363 | PubTator, text mining | PubMed |
| Switching off CK2-mediated activation of survivin offers new therapeutic opportunities in neuroblastoma. | Exp Mol Med | 2026 | 41571889 | PubTator, text mining | PubMed |
| Neutrophil extracellular traps as biomarkers for predicting prognosis and chemotherapy response in colorectal cancer. | Sci Rep | 2026 | 41571715 | PubTator, text mining | PubMed |
| Dual FLT3/PIM inhibitor dapolsertib in acute myeloid leukemia: results from the phase 1/2 DIAMOND-01 trial. | Blood Neoplasia | 2026 | 41536779 | PubTator, text mining | PubMed |
| More than CLK bait? Rogocekib for MDS and AML. | Blood Adv | 2026 | 41528737 | PubTator, text mining | PubMed |
| The antitumor mechanisms of Huangqin Houpo decoction and its effect on chemotherapy-induced toxicity in colorectal cancer. | Phytomedicine | 2026 | 41435607 | PubTator, text mining | PubMed |
| Biopsy and Blood Gene Expression Distinguish Injury, Subclinical and Clinical Rejection in Kidney Transplant Recipients. | Transplant Direct | 2026 | 41404547 | PubTator, text mining | PubMed |
| Genome-wide CRISPR-Cas9 screening identifies CLK1 inhibition as a strategy to restore PARP inhibitor sensitivity via ERCC1 isoform switching. | Protein Cell | 2026 | 41191919 | PubTator, text mining | PubMed |
| Phase 1 study of rogocekib in patients with relapsed or refractory hematologic malignancies. | Blood Adv | 2026 | 41056522 | PubTator, text mining | PubMed |
| Regulation of CLK1 Isoform Expression by Alternative Splicing in Activated Human Monocytes Contributes to Activation-Associated TNF Production. | Cells | 2025 | 41369414 | PubTator, text mining | PubMed |
| FeaSion decodes the regulatory landscape and functional diversity of RNA polymerase II CTD phosphorylation. | Sci Adv | 2025 | 41313762 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1195/papers?page=2